Phoenix Financial’s Takeda Pharmaceutical TAK Stock Holding History

Phoenix Financial’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,712	Closed	-$280K	–	405
2024 Q2	$280K	Sell	21,712 -33,385	-61%	-$442K	﹤0.01%	295
2024 Q1	$764K	Buy	+55,097	New	+$801K	0.01%	239
2023 Q3	–	Sell	-123,500	Closed	-$1.94M	–	365
2023 Q2	$1.94M	Buy	+123,500	New	+$2.02M	0.04%	168
2022 Q3	–	Sell	-71,380	Closed	-$977K	–	370
2022 Q2	$977K	Buy	+71,380	New	+$1.02M	0.02%	225

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Phoenix Financial's TAK Position: Q3 2024 in Review

Phoenix Financial sold out of Takeda Pharmaceutical (TAK) in Q3 2024, closing a stake of 21,712 shares — an estimated $280K sold.

Phoenix Financial first reported a position in TAK in Q2 2022 and held it in 4 quarters. The position peaked at $1.94M in Q2 2023. 298 funds tracked by Wall St. Rank hold TAK as of Q3 2024.

Phoenix Financial reported no remaining Takeda Pharmaceutical position as of Q3 2024 after selling out during the quarter.
Phoenix Financial sold 21,712 Takeda Pharmaceutical shares in Q3 2024, an estimated $280K.
Phoenix Financial first reported a position in Takeda Pharmaceutical in Q2 2022 and held it in 4 quarters.
Phoenix Financial's Takeda Pharmaceutical position peaked at $1.94M in Q2 2023.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2024.

Based on Phoenix Financial's 13F filing for Q3 2024, filed 5 Nov 2024.